CLINICALLY SIGNIFICANT PROSTATE CANCER
Clinical trials for CLINICALLY SIGNIFICANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CLINICALLY SIGNIFICANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CLINICALLY SIGNIFICANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood test could spot dangerous prostate cancer, spare men unneeded biopsies
Diagnosis Recruiting nowThis study is testing a new type of blood test that looks for genetic signals (exoRNA) to diagnose clinically significant prostate cancer. It aims to see if this test can accurately identify aggressive prostate cancer in men with elevated PSA levels, potentially offering a less i…
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC
-
New scan could spare men unnecessary prostate cancer treatment
Diagnosis Recruiting nowThis study is testing a new type of PET scan to help doctors better identify which men with low-risk prostate cancer can safely choose 'active surveillance'—monitoring the cancer without immediate surgery or radiation. Researchers want to see if this scan is more accurate than cu…
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Sponsor: Istanbul University - Cerrahpasa • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC